Related Experiment Video
Updated: Sep 5, 2025

13:51
Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
10.0K
Thermal Shift Assay for Small GTPase Stability Screening: Evaluation and Suitability.
Kari Kopra1, Salla Valtonen1, Randa Mahran1
1Department of Chemistry, University of Turku, Henrikinkatu 2, 20500 Turku, Finland.
International Journal of Molecular Sciences
|July 9, 2022
Summary
New thermal stability probes enhance biotherapeutic drug screening. The Protein-Probe offers superior sensitivity for nanomolar drug studies, improving upon existing methods like differential scanning fluorimetry.
Area of Science:
- Biochemistry
- Biophysics
- Pharmacology
Background:
- Thermal stability assays (TSA) are crucial for evaluating biotherapeutics.
- Differential scanning calorimetry (DSC) is a standard, but differential scanning fluorimetry (DSF) offers higher throughput for screening.
- Current DSF methods often lack sensitivity and present interpretation challenges.
Purpose of the Study:
- To compare the sensitivity and utility of three thermal stability probes: SYPRO Orange, 8-anilino-1-naphthalenesulfonic acid (ANS), and the Protein-Probe.
- To assess these probes for studying small GTPase stability, using KRAS as a model.
- To evaluate the probes' effectiveness in characterizing drug candidates, including small molecules and Designed Ankyrin Repeat Proteins.
Main Methods:
- Differential scanning fluorimetry (DSF) was employed to measure protein thermal stability.
- Three fluorescent probes (SYPRO Orange, ANS, Protein-Probe) were compared.
- Studies focused on KRAS protein stability in the presence of various drug candidates.
Main Results:
- The Protein-Probe demonstrated higher sensitivity and could be used at lower concentrations compared to SYPRO Orange and ANS.
- The Protein-Probe enabled effective drug screening at the nanomolar level for both non-covalent and covalent drug candidates.
- TSA profiles provided valuable biochemical insights into KRAS stability and drug interactions.
Conclusions:
- The Protein-Probe represents a significant advancement in thermal stability assays for biotherapeutic drug discovery.
- Its enhanced sensitivity and lower concentration requirements make it ideal for high-throughput screening and detailed mechanistic studies.
- This probe facilitates the characterization of drug effects on protein stability, aiding in the development of new therapeutics.

